Association of kinesiophobia with physical function, mental health and health-related quality of life in patients with obstructive airway disease: a cross-sectional study

Read full text Summarise with VIRAT
Authors: Ashriya Juriani, Bela M. Agarwal, Payal Murkudkar, Siddhika Kadam
Cited by: 0
References: 32

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The study aimed to evaluate the relationship of kinesiophobia with functional capacity, psychological distress, pulmonary function, and quality of life in individuals with obstructive airway disease and to determine the variables that independently predict kinesiophobia. A total of 111 clinically stable patients with obstructive airway disease were assessed using the Tampa Scale for Kinesiophobia (TSK), Numerical Rating Scale (NRS), Modified Medical Research Council Dyspnea Scale (mMRC), Fatigue Severity Scale (FSS), 6-Minute Walk Test (6MWT), International Physical Activity Questionnaire (IPAQ), arm curl test, 30-second sit-to-stand and flexibility tests, pulmonary function test, Depression Anxiety Stress Scale-21 (DASS-21), WHO Quality of Life-BREF (WHOQOL-BREF), and WHO Disability Assessment Schedule 2.0 (WHODAS 2.0). Clinically significant kinesiophobia (TSK>37) was observed in 64.8% of participants. TSK scores showed significant positive correlations with NRS (r=0.431), FSS (r=0.554), DASS-21 (r=0.456), WHODAS 2.0 (r=0.434), mMRC (r=0.309), and flexibility (back scratch test (r=0.281); and significant negative correlations with arm curl (r=-0.427), sit-to-stand (r=-0.433), 6MWT (r=-0.421), IPAQ (r=-0.421), and WHOQOL-BREF (r=-0.538), all with p

Fields of Study & Subjects

Chronic Obstructive Pulmonary Disease (COPD) Research Musculoskeletal pain and rehabilitation Asthma and respiratory diseases

Publication details

Journal / source
Monaldi Archives for Chest Disease
Publication date
30 March 2026
Language
EN